Adrenomedullin Blockade Suppresses Growth of Human Hormone–Independent Prostate Tumor Xenograft in Mice

Purpose: To study the role of the adrenomedullin system [adrenomedullin and its receptors (AMR), CLR, RAMP2, and RAMP3] in prostate cancer androgen-independent growth. Experimental Design: Androgen-dependent and -independent prostate cancer models were used to investigate the role and mechanisms of adrenomedullin in prostate cancer hormone-independent growth and tumor-associated angiogenesis and lymphangiogenesis. Results: Adrenomedullin and AMR were immunohistochemically localized in the carcinomatous epithelial compartment of prostate cancer specimens of high grade (Gleason score >7), suggesting a role of the adrenomedullin system in prostate cancer growth. We used the androgen-independent Du145 cells, for which we demonstrate that adrenomedullin stimulated cell proliferation in vitro through the cAMP/CRAF/MEK/ERK pathway. The proliferation of Du145 and PC3 cells is decreased by anti-adrenomedullin antibody (αAM), supporting the fact that adrenomedullin may function as a potent autocrine/paracrine growth factor for prostate cancer androgen-independent cells. In vivo, αAM therapy inhibits the growth of Du145 androgen-independent xenografts and interestingly of LNCaP androgen-dependent xenografts only in castrated animals, suggesting strongly that adrenomedullin might play an important role in tumor regrowth following androgen ablation. Histologic examination of αAM-treated tumors showed evidence of disruption of tumor vascularity, with depletion of vascular as well as lymphatic endothelial cells and pericytes, and increased lymphatic endothelial cell apoptosis. Importantly, αAM potently blocks tumor-associated lymphangiogenesis, but does not affect established vasculature and lymphatic vessels in normal adult mice. Conclusions: We conclude that expression of adrenomedullin upon androgen ablation in prostate cancer plays an important role in hormone-independent tumor growth and in neovascularization by supplying/amplifying signals essential for pathologic neoangiogenesis and lymphangiogenesis. Clin Cancer Res; 19(22); 6138–50. ©2013 AACR.

[1]  K. Camphausen,et al.  Aryl hydrocarbon receptor-induced adrenomedullin mediates cigarette smoke carcinogenicity in humans and mice. , 2012, Cancer research.

[2]  H. Scher,et al.  A gene signature identified using a mouse model of androgen receptor‐dependent prostate cancer predicts biochemical relapse in human disease , 2012, International journal of cancer.

[3]  Florence Tatin,et al.  Smooth muscle–endothelial cell communication activates Reelin signaling and regulates lymphatic vessel formation , 2012, The Journal of cell biology.

[4]  K. Alitalo,et al.  Lymphangiogenesis: Molecular Mechanisms and Future Promise , 2010, Cell.

[5]  S. Salas,et al.  Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear‐cell renal carcinoma , 2009, International journal of cancer.

[6]  Christophe Dussert,et al.  Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[8]  H. Dvorak,et al.  Why are tumour blood vessels abnormal and why is it important to know? , 2009, British Journal of Cancer.

[9]  K. Kangawa,et al.  Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema. , 2008, Cardiovascular research.

[10]  R. Puri,et al.  Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy. , 2008, Cancer research.

[11]  D. Figarella-Branger,et al.  Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates ‘neuroendocrine phenotype’ in LNCaP prostate tumor cells , 2008, Oncogene.

[12]  K. Caron,et al.  Adrenomedullin signaling is necessary for murine lymphatic vascular development. , 2008, The Journal of clinical investigation.

[13]  H. Friess,et al.  Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion , 2007, International journal of cancer.

[14]  R. Hwang,et al.  Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR. , 2007, Cancer research.

[15]  Michael Detmar,et al.  Tumor and lymph node lymphangiogenesis—impact on cancer metastasis , 2006, Journal of leukocyte biology.

[16]  Tatiana V. Petrova,et al.  Lymphangiogenesis in development and human disease , 2005, Nature.

[17]  S. Fox,et al.  Adrenomedullin and tumour angiogenesis , 2005, British Journal of Cancer.

[18]  Yihai Cao.  Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis , 2005, Nature Reviews Cancer.

[19]  S. Hirakawa,et al.  VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis , 2005, The Journal of experimental medicine.

[20]  S. Stacker,et al.  Focus on lymphangiogenesis in tumor metastasis. , 2005, Cancer cell.

[21]  G. Karsenty,et al.  Molecular analysis integrating different pathways associated with androgen-independent progression in LuCaP 23.1 xenograft , 2004, Oncogene.

[22]  P. Parnigotto,et al.  Adrenomedullin (AM) and AM receptor type 2 expression is up-regulated in prostate carcinomas (PC), and AM stimulates in vitro growth of a PC-derived cell line by enhancing proliferation and decreasing apoptosis rates. , 2004, International journal of oncology.

[23]  Toshio Ohhashi,et al.  PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. , 2004, Cancer cell.

[24]  T. Moody,et al.  Identification of vasoactive nonpeptidic positive and negative modulators of adrenomedullin using a neutralizing antibody-based screening strategy. , 2004, Endocrinology.

[25]  Christophe Dussert,et al.  Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: Involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors , 2004, International journal of cancer.

[26]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[27]  T. H. van der Kwast,et al.  Androgen‐independent expression of adrenomedullin and peptidylglycine α‐amidating monooxygenase in human prostatic carcinoma , 2003, Molecular carcinogenesis.

[28]  D. Hanahan,et al.  Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. , 2003, The Journal of clinical investigation.

[29]  F. Cuttitta,et al.  Adrenomedullin and cancer , 2003, Regulatory Peptides.

[30]  M. Asaka,et al.  Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis , 2003, Oncogene.

[31]  E. Manseau,et al.  Vascular Permeability Factor/Vascular Endothelial Growth Factor Induces Lymphangiogenesis as well as Angiogenesis , 2002, The Journal of experimental medicine.

[32]  K. Alitalo,et al.  Metastasis: Lymphangiogenesis and cancer metastasis , 2002, Nature Reviews Cancer.

[33]  K. Alitalo,et al.  Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. , 2002, Journal of the National Cancer Institute.

[34]  Patrick M. Sexton,et al.  International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors , 2002, Pharmacological Reviews.

[35]  M. Oehler,et al.  Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis , 2002, Oncogene.

[36]  N. Brünner,et al.  Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. , 2002, The American journal of pathology.

[37]  D. Feldman,et al.  The development of androgen-independent prostate cancer , 2001, Nature Reviews Cancer.

[38]  L. Ouafik,et al.  Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines. , 2001, Cancer research.

[39]  Thomas Hawighorst,et al.  Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis , 2001, Nature Medicine.

[40]  M. Gassmann,et al.  Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. , 2000, Molecular endocrinology.

[41]  D. Smith,et al.  Adrenomedullin, a multifunctional regulatory peptide. , 2000, Endocrine reviews.

[42]  J. Sato,et al.  MAP kinases, phosphatidylinositol 3‐kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor , 1999, Journal of cellular physiology.

[43]  S. Mahooti,et al.  Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. , 1998, Journal of cell science.

[44]  D. Bostwick,et al.  Independent origin of multiple foci of prostatic intraepithelial neoplasia , 1998, Cancer.

[45]  Melanie G. Lee,et al.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.

[46]  Lyna Zhang,et al.  PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium , 1998, Oncogene.

[47]  Frank Cuttitta,et al.  Adrenomedullin Expression in Human Tumor Cell Lines ITS POTENTIAL ROLE AS AN AUTOCRINE GROWTH FACTOR* , 1996, The Journal of Biological Chemistry.

[48]  K. Kangawa,et al.  Receptors for adrenomedullin in human vascular endothelial cells. , 1995, European journal of pharmacology.

[49]  Y. Kambayashi,et al.  Adrenomedullin Stimulates Two Signal Transduction Pathways, cAMP Accumulation and Ca2+ Mobilization, in Bovine Aortic Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[50]  D. Bostwick,et al.  Prostatic intraepithelial neoplasia (PIN). , 1989, Urology.

[51]  W. Jiang,et al.  Lymphangiogenesis and cancer metastasis. , 2011, Frontiers in bioscience.

[52]  M. Karkkainen,et al.  Lymphatic endothelium: a new frontier of metastasis research , 2002, Nature Cell Biology.